Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000899243-18-002328
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-30 20:58:24
Reporting Period:
2018-01-26
Accepted Time:
2018-01-30 20:58:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1609809 Seres Therapeutics Inc. MCRB Pharmaceutical Preparations (2834) 274326290
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1643736 Michele Trucksis C/o Seres Therapeutics, Inc.
200 Sidney Street
Cambridge MA 02139
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-26 7,500 $0.00 7,500 No 4 M Direct
Common Stock Disposition 2018-01-26 2,607 $11.02 4,893 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock RESTRICTED STOCK UNITS Disposition 2018-01-26 7,500 $0.00 7,500 $0.00
Common Stock STOCK OPTION (RIGHT TO BUY) Disposition 2018-01-30 95,000 $0.00 95,000 $10.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
30,000 No 4 M Direct
95,000 2028-01-29 No 4 A Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
  2. These restricted stock units have vested and settled or will vest and settle as to 20% of the restricted stock units on January 26, 2018, 30% on January 26, 2019; and 50% on January 26, 2020.
  3. The Option will vest as to 25% of the shares on January 30, 2019. The remainder of the shares will vest in 12 equal quarterly installments thereafter.